Anthony Lucero1, Niklas Eriksson2, Carli Nichta2, Kimberly Sokol2. 1. Department of Emergency Medicine, Kaweah Delta Medical Center, 400 West Mineral King Avenue, Visalia, CA, 93291, USA. anthony.lucero@vituity.com. 2. Department of Emergency Medicine, Kaweah Delta Medical Center, 400 West Mineral King Avenue, Visalia, CA, 93291, USA.
Abstract
BACKGROUND: Vaping-associated lung injury is a newly emerging disease process with the potential for serious health implications and high mortality, even despite the lack of underlying lung disease. We present a case of a young, otherwise healthy patient with tetrahydrocannabinol vaping-associated lung injury. CASE PRESENTATION: A 23-year-old Caucasian man with a past history of tetrahydrocannabinol vaping and benzodiazepine and methamphetamine abuse presented to the emergency department of our institution with a complaint of "feeling malnourished" over the past 5 days, along with associated fevers, cough, and vomiting. His past medical, surgical, family, and social histories were significant only for the recent use of marijuana vaping pens. Upon initial presentation, the patient appeared to be in significant respiratory distress. A computed tomographic scan of his chest demonstrated diffuse central predominant interstitial opacities, and he was admitted to the medical intensive care unit, where he was eventually intubated for hypoxic respiratory failure. No other cause of his respiratory failure was found, and it was ultimately believed that the patient had sustained a vaping-associated lung injury. CONCLUSION: Tetrahydrocannabinol-containing vaping-associated lung injury is still poorly understood overall and is currently being investigated by the Centers for Disease Control and Prevention. In the meantime, physicians should consider vaping to be a public health emergency. We summarize the appropriate history, physical examination, appropriate workup, and therapies that physicians should be aware of in order to appropriately manage and treat patients presenting with suspected vaping-associated lung injury.
BACKGROUND: Vaping-associated lung injury is a newly emerging disease process with the potential for serious health implications and high mortality, even despite the lack of underlying lung disease. We present a case of a young, otherwise healthy patient with tetrahydrocannabinol vaping-associated lung injury. CASE PRESENTATION: A 23-year-old Caucasian man with a past history of tetrahydrocannabinol vaping and benzodiazepine and methamphetamine abuse presented to the emergency department of our institution with a complaint of "feeling malnourished" over the past 5 days, along with associated fevers, cough, and vomiting. His past medical, surgical, family, and social histories were significant only for the recent use of marijuana vaping pens. Upon initial presentation, the patient appeared to be in significant respiratory distress. A computed tomographic scan of his chest demonstrated diffuse central predominant interstitial opacities, and he was admitted to the medical intensive care unit, where he was eventually intubated for hypoxic respiratory failure. No other cause of his respiratory failure was found, and it was ultimately believed that the patient had sustained a vaping-associated lung injury. CONCLUSION:Tetrahydrocannabinol-containing vaping-associated lung injury is still poorly understood overall and is currently being investigated by the Centers for Disease Control and Prevention. In the meantime, physicians should consider vaping to be a public health emergency. We summarize the appropriate history, physical examination, appropriate workup, and therapies that physicians should be aware of in order to appropriately manage and treat patients presenting with suspected vaping-associated lung injury.
Authors: Sean D Maddock; Meghan M Cirulis; Sean J Callahan; Lynn M Keenan; Cheryl S Pirozzi; Sanjeev M Raman; Scott K Aberegg Journal: N Engl J Med Date: 2019-09-06 Impact factor: 91.245
Authors: Jennifer E Layden; Isaac Ghinai; Ian Pray; Anne Kimball; Mark Layer; Mark W Tenforde; Livia Navon; Brooke Hoots; Phillip P Salvatore; Megan Elderbrook; Thomas Haupt; Jeffrey Kanne; Megan T Patel; Lori Saathoff-Huber; Brian A King; Josh G Schier; Christina A Mikosz; Jonathan Meiman Journal: N Engl J Med Date: 2019-09-06 Impact factor: 91.245
Authors: Sanjay Mukhopadhyay; Mitra Mehrad; Pedro Dammert; Andrea V Arrossi; Rakesh Sarda; David S Brenner; Fabien Maldonado; Humberto Choi; Michael Ghobrial Journal: Am J Clin Pathol Date: 2020-01-01 Impact factor: 2.493
Authors: Cria G Perrine; Cassandra M Pickens; Tegan K Boehmer; Brian A King; Christopher M Jones; Carla L DeSisto; Lindsey M Duca; Akaki Lekiachvili; Brandon Kenemer; Mays Shamout; Michael G Landen; Ruth Lynfield; Isaac Ghinai; Amy Heinzerling; Nathaniel Lewis; Ian W Pray; Lauren J Tanz; Anita Patel; Peter A Briss Journal: MMWR Morb Mortal Wkly Rep Date: 2019-10-04 Impact factor: 17.586
Authors: Isaac Ghinai; Ian W Pray; Livia Navon; Kevin O'Laughlin; Lori Saathoff-Huber; Brooke Hoots; Anne Kimball; Mark W Tenforde; Jennifer R Chevinsky; Mark Layer; Ngozi Ezike; Jonathan Meiman; Jennifer E Layden Journal: MMWR Morb Mortal Wkly Rep Date: 2019-10-04 Impact factor: 17.586